Relinking Diagnosed but Untreated HCV Patients Back Into Care.

Recruiting

• Conditions: Hepatitis C Virus Infection
• Interventions: Other: Contact the patient

• Registration Number: NCT05975216
• Lead Sponsor: Universitair Ziekenhuis Brussel

Brief Summary

Reintroduction of patients into a HCV infection care pathway after a positive chronic hepatitis C diagnosis by previous testing in our hospital who were lost in follow-up.

Gaining insight in the possible reasons why patients are lost in follow-up after positive hepatitis C serology.

Detailed Description

Not available

Study Timeline

• Study Start: 2023-07-06
• Study First Submitted: 2023-07-18
• Study First Submitted QC: 2023-08-01
• Study First Posted: 2023-08-03
• Status Verified: 2024-11
• Last Update Submitted: 2024-11-21
• Last Update Posted: 2024-11-25
• Primary Completion: 2026-07-31
• Study Completion: 2027-07-31

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 600

Inclusion Criteria

• Positive HCV serology between 2012-2022 with positive or uknown HCV RNA in UZ Brussels database
• ≥18 years

Exclusion Criteria

• Positive HCV serology with negative HCV RNA
• Previously eradicated patients in UZ Brussel

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Diagnosed-but-untreated	Contact the patient	Diagnosed but untreated (DBU) HCV patients through positive serology with positive or unknown HCV RNA in UZ Brussel between 2012 - 2022.

Primary Outcome Measures

Name	Time	Method
Retrospective data collection	before contacting the patient	Prevalence of diagnosed but untreated HCV patients through positive serology with positive or unknown HCV RNA in UZ Brussel between 2012 - 2022.
Prospective interventional study	from first contact of the patient till 12 weeks after end of treatment.	To recall DBU patients by phone, e-mail or letter, trying to optimize treated and cured patients after recall

Secondary Outcome Measures

Name	Time	Method
Reason lost in follow-up	from first contact of the patient till 12 weeks after end of treatment.	Understanding the different reasons why patients were lost in follow-up with the aim of improving our hospital quality in the future: * Unaware of positive hep C serology; * Follow-up or treatment in other centre; * Refusal of previously proposed therapy; * Other?

Trial Locations

Locations (1)

UZ Brussel; 🇧🇪 Brussel, Belgium